Nektar Therapeutics Stock Forecast

Stock Price Forecast

The 6 analysts that cover Nektar Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $81.67, which forecasts a 173.51% increase in the stock price over the next year. The lowest target is $30 and the highest is $120.

Price Target: $81.67 (+173.51%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$30	$81.67	$90	$120
Change	+0.47%	+173.51%	+201.41%	+301.88%

* Price targets were last updated on Jul 8, 2025.

Analyst Ratings

The average analyst rating for Nektar Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	3	4	4	4	4	4
Buy	2	2	2	2	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	6	6	6	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mayank Mamtani B. Riley Securities	B. Riley Securities	Strong Buy Maintains $60 → $85	Strong Buy	Maintains	$60 → $85	+184.66%	Jul 8, 2025
Arthur He HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $6.5 → $120	Strong Buy	Maintains	$6.5 → $120	+301.88%	Jun 24, 2025
Roger Song Jefferies	Jefferies	Hold → Strong Buy Upgrades $15 → $30	Hold → Strong Buy	Upgrades	$15 → $30	+0.47%	Apr 11, 2025
Jay Olson Oppenheimer	Oppenheimer	Hold → Buy Upgrades $90	Hold → Buy	Upgrades	$90	+201.41%	Mar 14, 2025
Arthur He HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $98	Strong Buy	Reiterates	$98	+226.52%	Mar 13, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

43.34M

from 98.43M

-55.97%

from 98.43M

Revenue Next Year

41.46M

from 43.34M

-4.33%

from 43.34M

EPS This Year

-12.04

from -8.68

EPS Next Year

-12.43

from -12.04

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	152.92M	101.91M	92.06M	90.12M	98.43M	43.34M	41.46M
Revenue Growth	33.41%	-33.36%	-9.67%	-2.10%	9.22%	-55.97%	-4.33%
EPS	-37.33	-42.90	-29.55	-21.79	-8.68	-12.04	-12.43
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	10	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	49.5M	54.6M
Avg	43.3M	41.5M
Low	38.8M	23.5M

Revenue Growth

Revenue Growth	2025	2026
High	-49.7%	26.0%
Avg	-56.0%	-4.3%
Low	-60.5%	-45.7%

EPS Forecast

EPS	2025	2026
High	-11.29	-9.18
Avg	-12.04	-12.43
Low	-13.55	-17.75

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.